Cited by 2,049Multiple Sclerosis Research StudiesViral-associated cancers and disordersCytomegalovirus and herpesvirus research

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik, Kjetil, Cortese, Marianna, Healy, Brian C., Kuhle, Jens, Mina, Michael J., Leng, Yumei, Elledge, Stephen J., Niebuhr, David W., Scher, Ann I., Munger, Kassandra L., Ascherio, Alberto·2022·Science

DOI 10.1126/science.abj8222

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr virus (EBV) in a cohort comprising more than 10 million young adults on active duty in the US military, 955 of whom were diagnosed with MS during their period of service. Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus. Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion. These findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.

Integrity signals

Registry

Crossref · 10.1126/science.abj8222

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Multiple sclerosis
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
The Immune Epitope Database (IEDB): 2018 update
Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S. R., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1006 · Cited by 2,194
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1601277 · Cited by 2,021
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T. P., Barcellos, L. F., & Alfredsson, L. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,263
Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis
Disanto, G., Barro, C., Benkert, P., Naegelin, Y., Schädelin, S., Giardiello, A., Zecca, C., Blennow, K., Zetterberg, H., Leppert, D., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24954 · Cited by 1,164
Epstein-Barr virus: exploiting the immune system
Thorley‐Lawson, D. A. (2001) · Nature reviews. Immunology · doi:10.1038/35095584 · Cited by 942

Flagged first, then by citations

Show all 51 references

1 of the 51 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 1,001

Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges
Chataway, J., Williams, T. E., Li, V., Marrie, R. A., Ontaneda, D., & Fox, R. J. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(24)00027-9 · Cited by 78
“22 However, ATA188 did not meet its primary outcome of sustained EDSS disability improvement; further details and secondary outcomes are awaited.”
Background
Origins and immunopathogenesis of autoimmune central nervous system disorders
Ramanathan, S., Brilot, F., Irani, S. R., & Dale, R. C. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00776-4 · Cited by 71
Repetitive elements in aging and neurodegeneration
Copley, K. E., & Shorter, J. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.02.008 · Cited by 70
Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans
Shams, H., Shao, X., Santaniello, A., Kirkish, G., Harroud, A., Ma, Q., Isobe, N., Alexander, J., Bove, R. M., Baranzini, S. E., et al. (2022) · Brain · doi:10.1093/brain/awac092 · Cited by 75
The Conundrum of Lung Disease and Drug Hypersensitivity‐like Reactions in Systemic Juvenile Idiopathic Arthritis
Binstadt, B. A., & Nigrovic, P. A. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42137 · Cited by 70
Endogenous Retroviruses as Modulators of Innate Immunity
Russ, E. U., & Iordanskiy, S. (2023) · Pathogens · doi:10.3390/pathogens12020162 · Cited by 74
mRNA vaccines: The future of prevention of viral infections?
Rzymski, P., Szuster‐Ciesielska, A., Dzieciątkowski, T., Gwenzi, W., & Fal, A. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28572 · Cited by 75
Potential biological contributers to the sex difference in multiple sclerosis progression
Álvarez‐Sánchez, N., & Dunn, S. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1175874 · Cited by 79
Correlation between the gut microbiome and neurodegenerative diseases: a review of metagenomics evidence
Liu, X., Liu, Y., Liu, J., Zhang, H., Shan, C., Guo, Y., Gong, X., Cui, M., Li, X., & Tang, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382223 · Cited by 75
Infection induces tissue-resident memory NK cells that safeguard tissue health
Schuster, I. S., Sng, X. Y. X., Lau, C. M., Powell, D., Weizman, O.-E., Fleming, P., Neate, G. E. G., Voigt, V., Sheppard, S., Maraskovsky, A. I., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.016 · Cited by 65
Central nervous system demyelinating diseases: glial cells at the hub of pathology
Costa, V. G. C., Espírito‐Santo, S., Alves‐Leon, S. V., & Gomes, F. C. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135540 · Cited by 73
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder — recommendations from ECTRIMS and the EBMT
Muraro, P. A., Mariottini, A., Greco, R., Burman, J., Iacobaeus, E., Inglese, M., Snowden, J. A., Alexander, T., Amato, M. P., Bø, L., et al. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-024-01050-x · Cited by 74
“…doses) 151 , the use of a high-intensity conditioning regimen and the MS disease itself, as the prevalence of EBV is high among people with MS 152 , yet the occurrence of EBV disease or EBV-associated post-transplant lymphoproliferative disorder (EBV–PTLD) is rare and can be managed with…”
Epstein–Barr virus pathogenesis and emerging control strategies
Münz, C. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01181-y · Cited by 69
“Compared with EBV seronegative individuals, primary EBV infection was found to increase MS risk more than 30-fold in a longitudinal American military personal cohort 12 .”
Influential
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice
Dasari, V., McNeil, L. K., Beckett, K. J., Solomon, M., Ambalathingal, G. R., Thuy, T. L., Panikkar, A., Smith, C., Steinbuck, M. P., Jakubowski, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39770-1 · Cited by 63
Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypes in vitro
SoRelle, E. D., Reinoso-Vizcaíno, N. M., Horn, G. Q., & Luftig, M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1001145 · Cited by 63
CD8+ T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer
Tedeschi, V., Paldino, G., Kunkl, M., Paroli, M., Sorrentino, R., Tuosto, L., & Fiorillo, M. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063374 · Cited by 65
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention
Carré, A., Vecchio, F., Flodström‐Tullberg, M., You, S., & Mallone, R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad007 · Cited by 64
Immunoinformatics Approach to Design Novel Subunit Vaccine against the Epstein-Barr Virus
Moin, A. T., Patil, R. B., Tabassum, T., Araf, Y., Ullah, M. A., Snigdha, H. J., Alam, T., Alvey, S. A., Rudra, B., Mina, S. A., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01151-22 · Cited by 60
Pre-existing conditions associated with post-acute sequelae of COVID-19
Jacobs, E. T., Catalfamo, C. J., Colombo, P. M., Khan, S. R., Austhof, E., Cordova-Marks, F. M., Ernst, K. C., Farland, L. V., & Pogreba-Brown, K. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102991 · Cited by 60
Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection
Hedström, A. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1212676 · Cited by 70
Update in clinical science: Autoimmune hepatitis
Heneghan, M. A., & Lohse, A. W. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2024.12.041 · Cited by 60
Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?
Gombash, S. E., Lee, P. W., Sawdai, E., & Lovett‐Racke, A. E. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.796933 · Cited by 65
Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection
SoRelle, E. D., Dai, J., Reinoso-Vizcaíno, N. M., Barry, A. P., Chan, C. C. W., & Luftig, M. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111286 · Cited by 56
How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?
Gallo, D., Baci, D., Kuštrimović, N. Z., Lanzo, N., Patera, B., Tanda, M. L., Piantanida, E., & Mortara, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054689 · Cited by 65
Artificial Intelligence and Multiple Sclerosis
Amin, M., Martínez‐Heras, E., Ontaneda, D., & Prados, F. (2024) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-024-01354-x · Cited by 69
“[4 , 5] The current diagnostic criteria for MS are codified in the 2017 McDonald criteria.”
Background
Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls
Sattarnezhad, N., Kockum, I. S., Thomas, O. G., Liu, Y., Ho, P. P.-K., Barrett, A. K., Comanescu, A. I., Wijeratne, T. U., Utz, P. J., Alfredsson, L. S., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2424986122 · Cited by 59
Autophagy pathways in autoimmune diseases
Keller, C. W., Adamopoulos, I. E., & Lünemann, J. D. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103030 · Cited by 58
Vaccination and immunotherapies in neuroimmunological diseases
Winkelmann, A., Loebermann, M., Barnett, M. H., Hartung, H., & Zettl, U. K. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00646-5 · Cited by 64
Microglial Priming in Infections and Its Risk to Neurodegenerative Diseases
Lima, M. N., Barbosa‐Silva, M. C., & Maron‐Gutierrez, T. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.878987 · Cited by 66
Fatty acids role in multiple sclerosis as “metabokines”
Yu, H., Bai, S., Hao, Y., & Guan, Y. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02502-1 · Cited by 63
How does neurovascular unit dysfunction contribute to multiple sclerosis?
Cashion, J. M., Young, K. M., & Sutherland, B. A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106028 · Cited by 58
Viral pathogens increase risk of neurodegenerative disease
Blackhurst, B. M., & Funk, K. E. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00790-6 · Cited by 57
Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer’s disease
Hyde, V. R., Zhou, C., y Fernández, J. R. M., Chatterjee, K., Ramakrishna, P., Lin, A., Fisher, G. W., Celiker, O. T., Caldwell, J., Bender, O., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115109 · Cited by 61
Radiologically isolated syndrome
Lebrun‐Frénay, C., Kantarci, O. H., Sıva, A., Azevedo, C. J., Makhani, N., Pelletier, D., & Okuda, D. T. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00281-8 · Cited by 65
Multiple sclerosis patient-derived spontaneous B cells have distinct EBV and host gene expression profiles in active disease
Soldan, S. S., Su, C., Monaco, M. C., Yoon, L., Kannan, T., Zankharia, U. S., Patel, R. J., Dheekollu, J., Vladimirova, O. V., Dowling, J. W., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01699-6 · Cited by 58
“8).”
Epstein-Barr virus as a driver of multiple sclerosis
Sollid, L. M. (2022) · Science Immunology · doi:10.1126/sciimmunol.abo7799 · Cited by 58
Effects of Oxysterols on Immune Cells and Related Diseases
de Freitas, F. A., Levy, D., Reichert, C. O., Cunha‐Neto, E., Kalil, J. E., & Bydlowski, S. P. (2022) · Cells · doi:10.3390/cells11081251 · Cited by 58
Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health
Pollock, N. R., Harrison, G. F., & Norman, P. J. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.04.036 · Cited by 60
Cytotoxic CD4+ T cells in chronic viral infections and cancer
Malyshkina, A., Brüggemann, A., Paschen, A., & Dittmer, U. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1271236 · Cited by 56
EBV and Lymphomagenesis
Sausen, D. G., Basith, A., & Muqeemuddin, S. (2023) · Cancers · doi:10.3390/cancers15072133 · Cited by 53
Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege
Ma, Y., Sannino, D. R., Linden, J. R., Haigh, S. V., Zhao, B., Grigg, J. B., Zumbo, P., Dündar, F., Butler, D., Profaci, C. P., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163239 · Cited by 51
The complement system in neurodegenerative and inflammatory diseases of the central nervous system
Negro‐Demontel, M. L., Maleki, A. F., Reich, D. S., & Kemper, C. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1396520 · Cited by 55
Family Herpesviridae and neuroinfections: current status and research in progress
Carneiro, V. C. D. S., Pereira, J. G., & de Paula, V. S. (2022) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760220200 · Cited by 51
Differential impact of environmental factors on systemic and localized autoimmunity
Touil, H., Mounts, K., & Jager, P. L. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1147447 · Cited by 57
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective
Escalante, G. M., Mutsvunguma, L. Z., Muniraju, M., Rodríguez, E., & Ogembo, J. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867918 · Cited by 50
Virological Markers in Epstein–Barr Virus-Associated Diseases
Lupo, J., Truffot, A., Andréani, J., Habib, M., Épaulard, O., Morand, P., & Germi, R. (2023) · Viruses · doi:10.3390/v15030656 · Cited by 52
Immune‐related adverse events after immune check point inhibitors: Understanding the intersection with autoimmunity
Singh, N., Hocking, A. M., & Buckner, J. H. (2023) · Immunological Reviews · doi:10.1111/imr.13247 · Cited by 50
Neoself-antigens are the primary target for autoreactive T cells in human lupus
Mori, S., Kohyama, M., Yasumizu, Y., Tada, A., Tanzawa, K., Shishido, T., Kishida, K., Jin, H., Nishide, M., Kawada, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.025 · Cited by 55
The role of the complement system in Multiple Sclerosis: A review
Saez-Calveras, N., & Stüve, O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.970486 · Cited by 51
Genetic risk factors for ME/CFS identified using combinatorial analysis
Das, S., Taylor, K., Kozubek, J. A., Sardell, J., & Gardner, S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03815-8 · Cited by 55
Unmasking the tissue-resident eukaryotic DNA virome in humans
Pyöriä, L., Pratas, D., Toppinen, M., Hedman, K., Sajantila, A., & Perdomo, M. F. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad199 · Cited by 48
Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis
Wang, P., Jiang, F., Zeng, Q., Yin, W., Hu, Y.-Z., Li, Q., & Hu, Z. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03016-8 · Cited by 52
“Additionally, environmental influences such as obesity, gut microbiota imbalance, virus infection, and smoking contribute to increased risks of developing MS, with Epstein–Barr virus (EBV) infection increasing the risk by 32-fold [14].”
Background
Multiple sclerosis: two decades of progress
Cree, B. A. C., Oksenberg, J. R., & Hauser, S. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00040-0 · Cited by 56
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
Biernacki, T., Kokas, Z., Sandi, D., Füvesi, J., Fricska‐Nagy, Z., Faragó, P., Kincses, Z. T., Klivènyi, P., Bencsik, K., & Vécsei, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063383 · Cited by 50
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Bernal‐Chico, A., Tepavčević, V., Manterola, A., Utrilla, C. L., Matute, C., & Mato, S. (2022) · Glia · doi:10.1002/glia.24172 · Cited by 50
Mycobacterium paratuberculosis zoonosis is a One Health emergency
Dow, C. T., & Alvarez, B. L. (2022) · EcoHealth · doi:10.1007/s10393-022-01602-x · Cited by 48
What SARS-CoV-2 does to our brains
Aschman, T., Mothes, R., Heppner, F. L., & Radbruch, H. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.013 · Cited by 50
Socioeconomic and race/ethnic differences in immunosenescence: Evidence from the Health and Retirement Study
Noppert, G. A., Stebbins, R. C., Dowd, J. B., & Aiello, A. E. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.019 · Cited by 51
Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments
Shechter, O., Sausen, D. G., Gallo, E. S., Dahari, H., & Borenstein, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214389 · Cited by 50
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review
Capasso, N., Virgilio, E., Covelli, A., Giovannini, B., Foschi, M., Montini, F., Nasello, M., Nilo, A., Prestipino, E., Schirò, G., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1207617 · Cited by 52
Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge
Malhi, H., Homad, L. J., Wan, Y.-H., Poudel, B., Fiala, B., Borst, A. J., Wang, J. Y., Walkey, C., Price, J., Wall, A., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100658 · Cited by 48
The role of virus infections in Sjögren’s syndrome
Maślińska, M., & Kostyra-Grabczak, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.823659 · Cited by 47
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases
Koers, J., Sciarrillo, R., Derksen, N. I. L., Vletter, E. M., Fillié‐Grijpma, Y. E., Raveling‐Eelsing, E., Graça, N. A. G., Leijser, T., Pas, H. H., van Nijen-Vos, L. L., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.10.035 · Cited by 47
New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: A review of 671 cases
Jeffery, N. D., & Granger, N. P. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1114798 · Cited by 48
The role of population-level preventive care for brain health in ageing
Sabayan, B., Doyle, S. J., Rost, N. S., Sorond, F. A., Lakshminarayan, K., & Launer, L. J. (2023) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(23)00051-x · Cited by 49
The Role of Gut Microbiome in the Pathogenesis of Multiple Sclerosis and Related Disorders
Dunalska, A., Saramak, K., & Szejko, N. (2023) · Cells · doi:10.3390/cells12131760 · Cited by 45
Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
Müller-Nedebock, A. C., Dekker, M. C. J., Farrer, M. J., Hattori, N., Lim, S., Mellick, G. D., Rektorová, I., Salama, M., Schuh, A. F. S., Stoessl, A. J., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00535-8 · Cited by 49
Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles
Aschman, T., Wyler, E., Baum, O., Hentschel, A., Legler, F., Preuße, C., Meyer‐Arndt, L., Büttnerova, I., Förster, A., Cengiz, D., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01662-2 · Cited by 48
The Potential for EBV Vaccines to Prevent Multiple Sclerosis
Maple, P. A. C., Ascherio, A., Cohen, J. I., Cutter, G., Giovannoni, G., Shannon-Lowe, C. D., Tănăsescu, R., & Gran, B. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.887794 · Cited by 47
Self-citation
Interplay between activation of endogenous retroviruses and inflammation as common pathogenic mechanism in neurological and psychiatric disorders
Gruchot, J., Herrero, F., Weber‐Stadlbauer, U., Meyer, U., & Küry, P. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.007 · Cited by 46
Expanded T lymphocytes in the cerebrospinal fluid of multiple sclerosis patients are specific for Epstein-Barr-virus-infected B cells
Gottlieb, A., Pham, H. P. T., Saltarrelli, J. G., & Lindsey, J. W. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2315857121 · Cited by 45
“Recent high - profile publications stimulated renewed interest in the role of EBV in MS. Bjornevik et al. (10) used the Department of Defense serum bank to demonstrate that infection with EBV increased risk of MS 32 - fold relative to uninfected subjects and concluded that EBV infection was necessary, but not sufficie…”
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease
Yogeshwar, S., Muñiz‐Castrillo, S., Sabater, L., Sempere, V. P., Mallajosyula, V. V. A., Luo, G., Yan, H., Yu, E., Zhang, J., Lin, L., et al. (2024) · Brain · doi:10.1093/brain/awae048 · Cited by 45
EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
Yang, T., You, C., Meng, S., Lai, Z., Ai, W., & Zhang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935205 · Cited by 47
The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology
Amoriello, R., Memo, C., Ballerini, L., & Ballerini, C. (2024) · Molecular Brain · doi:10.1186/s13041-024-01077-7 · Cited by 47
“Despite not definitively proven as the cause of MS, recent investigations strongly support EBV’s involvement in MS onset [64].”
Result
The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis
Kennedy, P. G. E., George, W., & Yu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147584 · Cited by 42
Emerging imaging and liquid biomarkers in multiple sclerosis
Gill, A. J., Schorr, E. M., Gadani, S. P., & Calabresi, P. A. (2023) · European Journal of Immunology · doi:10.1002/eji.202250228 · Cited by 52
Oral Dysbiosis and Neurodegenerative Diseases: Correlations and Potential Causations
Nicholson, J. S., & Landry, K. S. (2022) · Microorganisms · doi:10.3390/microorganisms10071326 · Cited by 43
Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis
Haro, I., Sanmartí, R., & Gomara, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415803 · Cited by 41
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis
Kujawa, D., Łaczmański, Ł., Budrewicz, S. P., Pokryszko‐Dragan, A., & Podbielska, M. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2274126 · Cited by 45
Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?
Broos, J. Y., van der Burgt, R. T. M., Konings, J., Rijnsburger, M., Werz, O., de Vries, H. E., Giera, M., & Kooij, G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02981-w · Cited by 41
Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases
Zhao, Y., Zhang, Q., Zhang, B., Dai, Y., Gao, Y., Li, C., Yu, Y., & Li, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158160 · Cited by 45
“Numerous studies have found that EBV can be detected in patients with a variety of diseases, such as nasopharyngeal carcinomas (NPCs) [8], gastric cancer [9], Hodgkin’s disease [10], Burkitt lymphoma [11], lymphoepithelial carcinoma [12], and multiple sclerosis [13].”
Background
Virology—The next fifty years
Holmes, E. C., Krammer, F., & Goodrum, F. D. (2024) · Cell · doi:10.1016/j.cell.2024.07.025 · Cited by 46
Myelin antigen capture in the CNS by B cells expressing EBV latent membrane protein 1 leads to demyelinating lesion formation
Kim, H. J., Schneider, M., Raach, Y., Karypidis, P., Roux, J., Perdikaris, G. A., Holdermann, S., Kulsvehagen, L., Lecourt, A.-C., Narr, K., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.031 · Cited by 45
HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms
Giménez-Orenga, K., Pierquin, J., Brunel, J., Charvet, B., Martín‐Martínez, E., Perron, H., & Oltra, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1020064 · Cited by 39
The association between vitamin D deficiency and multiple sclerosis: an updated systematic review and meta-analysis
Balasooriya, N. N., Elliott, T., Neale, R. Ε., Vasquez, P., Comans, T. A., & Gordon, L. G. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105804 · Cited by 40
Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis
Thomas, O. G., Rykaczewska, U., Galesic, M., van der Burgt, R. T. M., Hallen, N., Ferro, F., Bronge, M., Marti, Z., Li, Y., Rique, A. H., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.032 · Cited by 41
Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist
Baskaran, A. B., Grebenciucova, E., Shoemaker, T., & Graham, E. L. (2023) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.0208 · Cited by 48
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications
Chitnis, T., Magliozzi, R., Abdelhak, A., Kühle, J., Leppert, D., & Bielekova, B. (2025) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00249-2 · Cited by 47
New drugs for multiple sclerosis: new treatment algorithms
Cree, B., Hartung, H., & Barnett, M. H. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001063 · Cited by 41
Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents
Zhong, L., Zhang, W., Krummenacher, C., Chen, Y., Zheng, Q., Zhao, Q., Zeng, M., Xia, N., Zeng, Y., Xu, M., et al. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.03.001 · Cited by 37
Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes
Ma, Q., Shams, H., Didonna, A., Baranzini, S. E., Cree, B., Hauser, S. L., Henry, R. G., & Oksenberg, J. R. (2023) · Communications Biology · doi:10.1038/s42003-023-04713-5 · Cited by 45
Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival
Sausen, D. G., Poirier, M. C., Spiers, L. M., & Smith, E. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1289313 · Cited by 44
The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS—A Review Focusing on Neuroprotective Properties
Gavasso, S., Kråkenes, T., Olsen, H., Evjenth, E. C., Ytterdal, M., Haugsøen, J. B., & Kvistad, C. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031365 · Cited by 43
“Recent data show that infection with the Epstein–Barr virus (EBV) plays a crucial role in initiating pathogenic immunological events in MS [2].”
Background
Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis
Cortese, M., Leng, Y., Bjørnevik, K., Mitchell, M., Healy, B. C., Mina, M. J., Mancuso, J. D., Niebuhr, D. W., Munger, K. L., Elledge, S. J., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.0272 · Cited by 38
Self-citation
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation
Schneider‐Hohendorf, T., Wünsch, C., Falk, S., Raposo, C., Rubelt, F., Mirebrahim, H., Asgharian, H., Schlecht, U., Mattox, D. E., Zhou, W., et al. (2024) · Brain · doi:10.1093/brain/awae244 · Cited by 40
“…in MS, the CMV control analysis (at all time points) trended towards an overall narrower anti-CMV response in MS patients versus healthy donors ( P = 0.065), which is in line with earlier studies showing a lower anti-CMV antibody seroprevalence in MS patients 1,14,31,32 (Supplementary Fig.”
Influential
Deep learning enhances the prediction of HLA class I-presented CD8+ T cell epitopes in foreign pathogens
Wohlwend, J., Nathan, A., Shalon, N., Crain, C. R., Tano-Menka, R., Goldberg, B., Richards, E., Gaiha, G. D., & Barzilay, R. (2025) · Nature Machine Intelligence · doi:10.1038/s42256-024-00971-y · Cited by 41
“…practical utility of MUNIS, we experimentally assessed predictions of epitope binding and immunogenicity within the EBV proteome for several HLA-I alleles, given its relevance to immuno-compromised populations 38 , linkage to multiple sclerosis 39,40 and >90% prevalence in the human population 41 .”
Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome
Rival, M., Galoppin, M., & Thouvenot, É. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.866092 · Cited by 41
Multiple Sclerosis and Microbiome
Preiningerova, J. L., Zakostelska, Z. J., Srinivasan, A., Tichá, V., Kovářová, I., Kleinová, P., Tlaskalová-Hogenová, H., & Havrdová, E. (2022) · Biomolecules · doi:10.3390/biom12030433 · Cited by 43
Gammaherpesvirus infection drives age-associated B cells toward pathogenicity in EAE and MS
Mouat, I. C., Allanach, J. R., Fettig, N. M., Fan, V., Girard, A. M., Shanina, I., Osborne, L. C., Vorobeychik, G., & Horwitz, M. S. (2022) · Science Advances · doi:10.1126/sciadv.ade6844 · Cited by 40
Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism
Thomas, O. G., Rickinson, A. B., & Palendira, U. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1451 · Cited by 40

Authors: Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., & Ascherio, A.
Affiliations: Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Harvard University (US)
Brigham and Women's Hospital (US)
Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Uniformed Services University of the Health Sciences (US)
Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Corresponding author: Cortese, Marianna
Munger, Kassandra L.
Ascherio, Alberto
ORCID: Bjornevik, Kjetil
Cortese, Marianna
Healy, Brian C.
Mina, Michael J.
Leng, Yumei
Elledge, Stephen J.
Munger, Kassandra L.
Ascherio, Alberto
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2022-01-21
Volume: 375
Issue: 6578
Pages: 296-301
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.abj8222
OpenAlex: W4205972999
Cited by: 2,049
References: 51
Citations by year: 2026: 354 · 2025: 412 · 2024: 461 · 2023: 432 · 2022: 388
FWCI: 289.56
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
National Institute of Neurological Disorders and Stroke (R01NS042194, R01NS046635, R01NS103891)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords: multiple sclerosis, Epstein-Barr virus, viral etiology, neurofilament light chain, neuroaxonal degeneration, cytomegalovirus, demyelinating disease, military personnel
MeSH terms: Antibodies, Viral, Cytomegalovirus, Herpesvirus 4, Human, Female, Humans, Longitudinal Studies, Male, Military Personnel, Multiple Sclerosis, Risk Factors, Cohort Studies, Biomarkers, Prevalence, Neurofilament Proteins, Age of Onset, Epstein-Barr Virus Infections, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks